Trials / Unknown
UnknownNCT05085184
Study to Evaluate the Safety and PK of UI018
A Randomized, Open, Single-dose, 2x2x4 Replicate Crossover-design Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics After Co-administration of UIC201806 and UIC201602 or Administration of UI018 in Healthy Volunteers
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Korea United Pharm. Inc. · Industry
- Sex
- All
- Age
- 19 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This Study is to evaluate the safety and pharmacokinetics of a fixed dose combination formulation and co-administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | administration of UI018 | Test |
| DRUG | co-administration of UIC201806 and UIC201602 | Reference |
Timeline
- Start date
- 2021-09-06
- Primary completion
- 2021-11-30
- Completion
- 2022-09-05
- First posted
- 2021-10-20
- Last updated
- 2021-12-21
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05085184. Inclusion in this directory is not an endorsement.